What makes this raffle distinctive is the dramatic disparity between ticket cost and artwork value—a €1 million painting sold at €100 per ticket creates an immediate understanding of the fundraising advantage. The painting itself has historical significance as a work from Picasso’s wartime period in occupied France, adding cultural weight to the prize beyond its market value. For dementia advocates and supporters, this represents a tangible way to contribute to brain health research while supporting a genuinely transformative cause.
Table of Contents
- How Does a €100 Ticket Offer a €1 Million Painting?
- The Picasso Masterpiece—A 1941 Work From France’s Occupation Era
- The Beneficiary Organization and Its Research Mission
- The Odds, the Real Investment, and Comparing to Alternative Giving Models
- Historical Performance—What the 2020 Edition Achieved
- Participation Details and Timeline
- The Growing Trend of High-Value Art Auctions for Health Research
- Conclusion
How Does a €100 Ticket Offer a €1 Million Painting?
The mathematics of this raffle highlight why it works as a fundraising mechanism: 120,000 tickets at €100 each generate €12 million in gross revenue. Opera Gallery, a partner in the campaign, receives €1 million from that pool, while the remainder supports the Alzheimer’s Research Foundation’s work. From a pure probability standpoint, any single ticket holder has a 1 in 120,000 chance of winning the Picasso.
However, the value proposition shifts when viewed as a donation: even if you never win, your €100 contributes directly to dementia prevention research that could affect millions of families—a clearer outcome than most individual donations achieve. The ticket structure also allows for international participation, which broadens both the pool of supporters and the campaign’s reach into different healthcare and research communities. Unlike traditional gallery-based auctions that require significant wealth to participate, this model opens Picasso ownership (theoretically) to anyone with €100 to spend.
The Picasso Masterpiece—A 1941 Work From France’s Occupation Era
The painting being raffled, *Tête de femme*, was created in 1941 during one of the most significant periods in art history—when Nazi Germany occupied France and Picasso remained in Paris despite the risks. this work exemplifies the artist’s continued innovation during artistic suppression; the gouache medium (pigment bound with water-soluble gum) allowed for subtle tonal variations impossible in oil. The head itself is rendered in Picasso’s characteristic cubist fragmentation, breaking the human face into geometric planes that suggest multiple simultaneous perspectives.
However, artwork at this price point comes with considerations beyond aesthetic appeal. Insurance, transportation, climate-controlled storage, and authentication all require professional management that private collectors must budget for separately. The painting’s value is also subject to market fluctuations; while €1 million+ is the current estimate, art values shift with market conditions, exhibition history, and provenance documentation. For a winner without prior art collection experience, consulting with a specialized insurance broker and conservator would be essential before taking possession.
The Beneficiary Organization and Its Research Mission
The Alzheimer’s Research Foundation (Fondation pour la Recherche sur l’Alzheimer), based in Paris, concentrates on understanding and preventing dementia through neuroscience research. The foundation funds laboratory work, clinical trials, and emerging research into early detection biomarkers—the measurable indicators that allow researchers to identify cognitive decline before symptoms appear.
Proceeds from this raffle directly support these research streams, which have implications not just for Alzheimer’s disease but for broader neurodegenerative conditions. The partnership with Opera Gallery adds a distribution and promotional dimension; a global art gallery network can reach collectors and supporters outside traditional medical fundraising circles. This cross-sector approach has proven effective: the 2020 edition of this raffle raised €5.1 million for CARE International, demonstrating that public appetite for high-value art raffles supporting charitable causes is substantial when properly executed.
The Odds, the Real Investment, and Comparing to Alternative Giving Models
With 120,000 tickets available worldwide, the probability of winning stands at 0.0008%—statistically equivalent to buying a single lottery ticket in a mid-sized national lottery. This means potential participants should view the €100 as a donation first and the prize as an unlikely (though possible) bonus. When positioned this way, the raffle becomes comparable to structured giving vehicles: a €100 donation to medical research through conventional channels provides a tax deduction in many jurisdictions, while a raffle ticket provides neither tax benefit nor guaranteed outcome, but offers the psychological appeal of a tangible prize.
A practical comparison: €100 donated directly to the Alzheimer’s Research Foundation achieves the same research impact with guaranteed charitable tax treatment in France. The raffle ticket, by contrast, bundles the donation with entertainment value and a microscopically small chance of extraordinary return. The decision between these approaches depends on individual circumstances—whether the person values the engagement element of a public draw versus the administrative certainty of direct donation.
Historical Performance—What the 2020 Edition Achieved
The previous iteration of this campaign, held in 2020, offered a Picasso *Nature Morte (Still Life)* from 1921 and raised €5.1 million ($5.9 million USD). The winner was Claudia Borgogno from Ventimiglia, Italy, who held one of 120,000 tickets sold. That edition benefited CARE International, which directed funds toward water access and sanitation infrastructure in Cameroon, Madagascar, and Morocco—a significantly different cause from the current dementia focus.
This historical data reveals two important insights: first, that the €12 million ticket revenue does not all reach research; operational costs, marketing, and partner fees consume a meaningful portion. The €5.1 million that reached CARE represented roughly 43% of gross revenue, suggesting similar proportions for the current edition. Second, the winner’s identity being publicly documented (and willing to be named) adds legitimacy to the campaign—this is not a hidden-payout scheme but a transparent, verifiable process coordinated through a major auction house. Winners from previous editions remain verifiable through public records and art registration databases.
Participation Details and Timeline
The draw takes place April 14, 2026, at Christie’s Paris location, which serves as a credible, neutral venue independent of any single organization—reducing concerns about manipulation or opaqueness. Tickets are available globally, making this campaign accessible to dementia supporters, art enthusiasts, and philanthropists across continents.
The 120,000-ticket cap creates genuine scarcity rather than unlimited sales that would dilute each individual ticket’s symbolic value. For potential participants outside France, currency conversion, international payment processing, and shipping of the physical artwork (should someone win from abroad) are considerations. Raffle organizers typically handle logistics, but winners should anticipate customs declarations and transport costs, particularly if the painting needs to travel intercontinentally.
The Growing Trend of High-Value Art Auctions for Health Research
This raffle sits within a broader trend of cultural institutions and foundations partnering to merge art access with healthcare fundraising. The model has proven successful beyond Picasso; similar campaigns have emerged around works by other major 20th-century artists, generally raising €3 million to €12 million per campaign. The durability of these initiatives suggests that public trust in art-as-fundraising remains strong, particularly when a transparent auction house (like Christie’s) oversees the draw process.
Looking forward, dementia research funding faces sustained gaps between what research institutions need and what traditional sources provide. Alternative funding vehicles like high-value art raffles may increasingly serve as bridges to close those gaps, especially as aging populations make neurodegeneration a societal priority. The success of the 2020 edition suggests this third iteration will likely meet or exceed those historical results.
Conclusion
The “1 Picasso for 100 Euros” raffle represents an innovative model for dementia research fundraising: bundling a verifiable charitable donation with transparent governance, global reach, and a historically significant artwork prize. The €1 million Picasso *Tête de femme* from 1941 is the draw incentive, but the real value for supporters lies in knowing that participation channels resources directly into Alzheimer’s and dementia prevention research conducted by a Paris-based foundation with documented track record.
For anyone with interest in supporting brain health research, dementia prevention, or both—combined with engagement in the art world or charitable giving—the campaign runs through April 14, 2026. Tickets are available internationally at €100 each through official campaign channels. Even for those who view the probability of winning as negligible, the donation achieved through ticket purchase supports research that may benefit millions of families affected by cognitive decline.
You Might Also Like
- Exercise-Boosted Liver Enzyme Tied to Alzheimer’s Protection
- Exercise Can Lower Alzheimer’s Risk According to New Research
- Brain Health Collaboratory Focuses on Non-Invasive Alzheimer’s Therapy
For more, see Alzheimer’s Association — caregiving.
